News
Mankind Pharma consolidated net profit declines 18.30% in the June 2025 quarter
31-Jul-2025 | 18:02
Sales rise 24.50% to Rs 3570.35 crore
Net profit of Mankind Pharma declined 18.30% to Rs 438.32 crore in the quarter ended June 2025 as against Rs 536.49 crore during the previous quarter ended June 2024. Sales rose 24.50% to Rs 3570.35 crore in the quarter ended June 2025 as against Rs 2867.85 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 3570.35 | 2867.85 | 24 |
| OPM % | 23.72 | 23.42 | - |
| PBDT | 759.17 | 764.03 | -1 |
| PBT | 540.49 | 661.34 | -18 |
| NP | 438.32 | 536.49 | -18 |
Powered by Capital Market - Live News